Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1067 | 951 | 1125 | 1134 | 1343 | - |
Fund Return | 6.7% | -4.92% | 12.47% | 4.27% | 6.08% | - |
Place in category | 431 | 490 | 405 | 161 | 238 | - |
% in Category | 64 | 73 | 62 | 27 | 40 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 619.45B | 28.05 | 11.42 | 13.34 | ||
Fidelity Contrafund | 140.4B | 37.26 | 11.61 | 15.33 | ||
Fidelity Contrafund K | 12.59B | 37.40 | 11.71 | 15.44 | ||
Fidelity Total Market Index Instl b | 104.68B | 27.73 | 10.41 | 12.84 | ||
Fidelity Blue Chip Growth | 67.04B | 37.89 | 9.30 | 17.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 206B | 7.87 | 2.85 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.27B | 7.92 | 2.90 | 4.95 | ||
Fidelity International Index Inst | 51.28B | 6.73 | 4.26 | 5.28 | ||
Fidelity Series Global ex US Index | 50.22B | 8.01 | 2.94 | 4.71 | ||
Strategic Advisers International I | 44.17B | 8.62 | 3.15 | 6.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.16 | 637.5 | -0.20% | |
ASML Holding | NL0010273215 | 1.61 | 688.00 | -0.29% | |
Nestle | CH0038863350 | 1.48 | 74.70 | -0.24% | |
SAP | DE0007164600 | 1.46 | 234.850 | -1.55% | |
AstraZeneca | GB0009895292 | 1.32 | 10,594.0 | -0.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review